Jeffrey Busch - Global Medical Chairman
| GMRE Stock | USD 8.37 0.11 1.30% |
Chairman
Mr. Jeffrey Busch serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Busch was an active investor in the real estate industry since 1985. Since 2013, Mr. Busch has served as President of InterAmerican Management. Mr. Busch also has served as a director of the Company since September 30, 2014 and served as Chairman and President of the Company from August 13, 2015 to the present. From October 7, 2014 Mr. Busch served as Director and Vice Chairman of American Housing REIT Inc. fka OnTarget 360, which is also externally managed by our Advisor, and from October 7, 2014 to the present has served as its Chairman. His experience includes developing numerous properties in various asset classes, owning and managing real estate in several states, including rental housing, and a wide variety of commercial real estate. Since 2001, Mr. Busch has also served as President of Safe Blood International Foundation, where he oversees the establishment of medical facilities in 35 developing nations, funded by the U.S. Center for Disease Control and USAID, Exxon Mobil, and the Gates Foundation. Mr. Busch has had presidential appointments in two presidential administrations, one in the Department of Housing and Urban Affairs and the other at the United Nations in Geneva, where he served as a United States delegate since 2017.
| Age | 64 |
| Tenure | 8 years |
| Address | 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814 |
| Phone | 202 524 6851 |
| Web | https://www.globalmedicalreit.com |
Jeffrey Busch Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jeffrey Busch against Global Medical stock is an integral part of due diligence when investing in Global Medical. Jeffrey Busch insider activity provides valuable insight into whether Global Medical is net buyers or sellers over its current business cycle. Note, Global Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Global Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jeffrey Busch over a week ago Acquisition by Jeffrey Busch of 62176 shares of Global Medical subject to Rule 16b-3 |
Global Medical Management Efficiency
The company has return on total asset (ROA) of 0.0163 % which means that it generated a profit of $0.0163 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0115 %, meaning that it created $0.0115 on every $100 dollars invested by stockholders. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.01, whereas Return On Equity is forecasted to decline to 0.01. At present, Global Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 666.7 M, whereas Non Current Assets Total are forecasted to decline to about 836.4 M.Similar Executives
| Found 7 records | CHAIRMAN Age | ||
| Richard Matros | Sabra Healthcare REIT | 71 | |
| Timothy Wallace | Community Healthcare Trust | 65 | |
| Tommy Thompson | Healthpeak Properties | 78 | |
| Debra Cafaro | Ventas Inc | 67 | |
| John Singleton | Healthcare Realty Trust | 72 | |
| Craig Callen | Omega Healthcare Investors | 64 | |
| Alan Miller | Universal Health Realty | 87 | |
Management Performance
| Return On Equity | 0.0115 | ||||
| Return On Asset | 0.0163 |
Global Medical REIT Leadership Team
Elected by the shareholders, the Global Medical's board of directors comprises two types of representatives: Global Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Medical's management team and ensure that shareholders' interests are well served. Global Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henry Cole, Lead Independent Director | ||
| Matthew Cypher, Independent Director | ||
| Robert CPA, CFO Treasurer | ||
| Robert Kiernan, Chief Financial Officer, Treasurer | ||
| Jingguo Zhang, Director | ||
| Huiqi Zhang, Director | ||
| Jamie Barber, General Counsel, Secretary | ||
| Roscoe Moore, Independent Director | ||
| Stephen Swett, Investor Executive | ||
| Ronald Marston, Independent Director | ||
| Jeffery Busch, President Chairman | ||
| Jeffrey JD, President Chairman | ||
| Lori Wittman, Independent Director | ||
| Paula Crowley, Independent Director | ||
| Danica Holley, Chief Operating Officer | ||
| Mary Jensen, Investor Professional | ||
| Alfonzo Leon, Chief Investment Officer | ||
| Allen Webb, Senior Vice President - SEC Reporting and Technical Accounting | ||
| Jeffrey Busch, Chairman of the Board , President , Chief Executive Officer |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0115 | ||||
| Return On Asset | 0.0163 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 1.3 B | ||||
| Shares Outstanding | 66.87 M | ||||
| Shares Owned By Insiders | 5.64 % | ||||
| Shares Owned By Institutions | 63.69 % | ||||
| Number Of Shares Shorted | 1.34 M | ||||
| Price To Earning | 39.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.066 |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.